ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Crinetics Pharmaceuticals, INC.

Official 2024 U.S. DOL Form 5500 summary for Crinetics Pharmaceuticals, INC. (Crinetics Pharmaceuticals, INC. 401(k) Plan · EIN 26-3744114 · PN 001): $29.66M net assets, 428 active participants, and $13.12 per $10,000 (13.12 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorCrinetics Pharmaceuticals, INC.
Filing IdentifierCrinetics Pharmaceuticals, INC. 401(k) Plan · EIN 26-3744114 · PN 001
Plan Category & State401(k) Defined Contribution (CA)
Asset-Size Peer Cohort$5M-$25M
Plan Net Assets (2024)$29.66M
Active Participants428
Direct Admin Fee Rate$13.12 per $10,000 (13.12 bps)
Cohort Peer Median$37.06 per $10,000 (37.06 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI